Siiki Antti, Laukkarinen Johanna
Duodecim. 2017;133(3):267-74.
Endoscopic retrograde cholangiopancreatography (ERCP) is the primary method for treating cholestasis and biliary tract gallstones. Although noninvasive imaging has replaced ERCP in diagnostics, ERCP remains the mainstay in collecting diagnostic specimens from the biliary tract. ERCP carries a risk of post-ERCP pancreatitis, which can vary from mild to life-threatening. Difficult cannulation is the most important risk factor for pancreatitis. Careful patient selection and adequate endoscopy training are the foundation of safe ERCP practice. Current evidence supports the routine use of prophylactic rectal NSAID in all patients to prevent post-ERCP pancreatitis.
内镜逆行胰胆管造影术(ERCP)是治疗胆汁淤积和胆道结石的主要方法。尽管非侵入性成像在诊断中已取代了ERCP,但ERCP仍是从胆道收集诊断标本的主要手段。ERCP存在术后胰腺炎的风险,其严重程度可从轻度到危及生命不等。插管困难是胰腺炎最重要的危险因素。谨慎选择患者和进行充分的内镜培训是安全实施ERCP的基础。目前的证据支持在所有患者中常规使用预防性直肠非甾体抗炎药以预防ERCP术后胰腺炎。